UroViu
Private Company
Total funding raised: $15M
Overview
UroViu is a private, commercial-stage medical device company pioneering portable, single-use endoscopy systems for urology and gynecology. Its core innovation is a reusable, battery-powered console paired with sterile, disposable scopes, which eliminates capital costs, reprocessing burdens, and cross-contamination risks associated with traditional reusable endoscopes. The company has a vertically integrated structure, holds over 30 patents, and has secured FDA 510(k) clearances and CE certification for its platforms, positioning it to capture share in the growing disposable endoscopy market. Key challenges include scaling manufacturing, navigating reimbursement, and competing against established device giants and other single-use entrants.
Technology Platform
Portable, reusable endoscopy console paired with sterile, single-use digital endoscopes for cystoscopy and hysteroscopy. Platform includes battery power, HD display, and Wi-Fi connectivity.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
UroViu competes in the single-use endoscopy space against large incumbents like Olympus, Karl Storz, and Boston Scientific, who are launching their own disposable scopes, and against dedicated single-use companies like Ambu. Differentiation is based on a fully portable, all-in-one platform, a specialized urology/gynecology focus, and high-definition imaging in a disposable format.